baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC BON.CAP.CERT. 06/24 PFE/ DE000HD3TWY5 /

2024-04-30 9:45:04 PM	Chg.-0.580	Bid9:59:59 PM	Ask9:59:59 PM	Underlying	Strike price	Expiration date	Option type
34.780EUR	-1.64%	34.770 Bid Size: 4,000	34.800 Ask Size: 4,000	Pfizer Inc	- USD	2024-06-28	Call

GlobeNewswire 05-01 Giants of Cancer Care® Announces the 12th Annual Class of Inductees

TeleTrader 05-01 Pfizer's Q1 revenue drops 20% to $14.9 billion

GlobeNewswire 04-30 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...

GlobeNewswire 03-22 Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous ...

GlobeNewswire 03-20 Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook

GlobeNewswire 03-07 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...

GlobeNewswire 03-05 LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd...

GlobeNewswire 02-28 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...

GlobeNewswire 02-27 Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment t...

GlobeNewswire 02-23 Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market

GlobeNewswire 02-16 ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Befo...

GlobeNewswire 02-08 ROSEN, A RANKED AND LEADING FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Importan...

GlobeNewswire 02-06 Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment o...

TeleTrader 01-30 Pfizer posts Q4 revenue of $14B, reaffirms guidance

GlobeNewswire 01-26 ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadl...

GlobeNewswire 2023-12-21 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 2023-12-19 Related Sciences Adds 8 New Senior Advisors Including Former CEOs and Heads of R&D from Genentech, N...

GlobeNewswire 2023-12-13 Arch Biopartners Submits Application to Health Canada to Conduct the Phase II Cardiac Surgery Associ...

TeleTrader 2023-12-13 Pfizer sees full-year 2024 revenue of $58.5 to $61.5 billion

TeleTrader 2023-12-12 Pfizer gets regulatory clearance to buy Seagen for $43 billion

GlobeNewswire 2023-12-05 Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Pa...

GlobeNewswire 2023-12-04 Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, ...

GlobeNewswire 2023-12-04 Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors

TeleTrader 2023-12-01 Pfizer down 4% on call to scrap weight-loss pill trial

TeleTrader 2023-11-30 Pfizer sued by Texas over vaccine efficacy

UC BON.CAP.CERT. 06/24 PFE/ DE000HD3TWY5 /

If you wish to receive reply to your feedback, please provide your email address.